Related Experiment Video
Updated: Mar 19, 2026

07:30
Learning Modern Laryngeal Surgery in a Dissection Laboratory
Published on: March 18, 2020
8.8K
A Study of Layered Learning in Oncology
Jill S Bates1, Larry W Buie1, Kayley Lyons2
1University of North Carolina Medical Center, Chapel Hill, North Carolina.
American Journal of Pharmaceutical Education
|June 14, 2016
Summary
Pharmacy learners in a layered learning practice model (LLPM) positively impacted patient care and skill development. This innovative educational approach did not hinder knowledge acquisition, supporting its use in pharmacy practice experiences.
Area of Science:
- Pharmacy Education
- Oncology Pharmacy Practice
- Experiential Learning
Background:
- Traditional pharmacy practice models face challenges in expanding services and optimizing learner experiences.
- The integration of learners into clinical settings requires structured approaches to ensure educational objectives are met.
- Layered learning offers a potential framework for enhancing pharmacy services through trainee involvement.
Purpose of the Study:
- To investigate the efficacy of a layered learning practice model (LLPM) in expanding oncology pharmacy services.
- To determine if the LLPM environment impedes the attainment of knowledge-based learning objectives for pharmacy learners.
- To evaluate pharmacy learners' perceptions of their experience within the LLPM.
Main Methods:
- Redesigning an acute care oncology pharmacy practice experience to incorporate LLPM principles.
- Implementing micro-discussions, standardized feedback using rubrics, and cooperative learning strategies.
- Assessing knowledge-based learning objectives through pretest and posttest evaluations.
Main Results:
- Posttest scores demonstrated a significant increase in the mean percentage of knowledge-based learning objectives compared to pretest values.
- Pharmacy learners reported positive perceptions regarding knowledge attainment, clinical time management, and patient care contributions.
- Learners also noted improvements in clinical and self-management skills, along with increased comfort with the learning environment.
Conclusions:
- The layered learning practice model (LLPM) was well-received by pharmacy learners in an oncology setting.
- The LLPM environment supports the achievement of knowledge-based learning objectives, contrary to potential concerns.
- Findings suggest the LLPM is a viable model for pharmacy education and warrants further investigation.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine
1.7K
1.7K
Treatment Resistent Cancers
1.5K
1.5K
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies
3.0K
3.0K

